Results 151 to 160 of about 46,097 (193)

Stereotactic Radiosurgery and Highly Active Antiretroviral Therapy for HIV-Related Primary Central Nervous System Lymphomas: A Prospective Study Analyzing the Efficacy and Safety. [PDF]

Neurosurg Pract
Alvarez Pinzon AM, Ramon Alonso J, Wolf A, Ramirez-Velandia F, Valerio JE.   +4 more
europepmc   +1 more source

TB co-infection and associated factors among HIV patients attending highly active antiretroviral therapy in Saint Peter's TB Specialized Hospital, Ethiopia: a five years retrospective study. [PDF]

Afr Health Sci
Getaw D, Tigu F.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Highly active antiretroviral therapy

The Lancet, 1998
Letter to the ...
VENTO, Sandro, C. Renzini, F. Casali, G. Ghironzi, CONCIA, Ercole   +4 more
  +11 more sources

The relationship of pregnancy to the use of highly active antiretroviral therapy

American Journal of Obstetrics and Gynecology, 2001
Public health agencies have recommended that the criteria for the use of highly active antiretroviral therapy should not be modified because of pregnancy. However, little information has been published with regard to the degree to which these recommendations are being followed.
H, Minkoff, L, Ahdieh, H, Watts, R M, Greenblatt, J, Schmidt, M, Schneider, A, Stek   +6 more
openaire   +4 more sources

ADHERENCE TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

Nursing Clinics of North America, 1999
Advances in scientific understanding of and pharmacologic therapies for HIV infection have significantly increased the potential benefits of medical regimens. Patients adherence to these regimens is an essential antecedent to therapeutic effectiveness. Nursing interventions to improve adherence target the patient, the clinician, and the regimen.
openaire   +2 more sources

The oncology impact of highly active antiretroviral therapy

Journal of Oncology Pharmacy Practice, 2007
Objective. To examine the impact of using highly active antiretroviral therapy (HAART) in a human immunodeficiency virus (HIV) infected population on the chemotherapy related costs of treating acquired immunodeficiency (AIDS)-related cancers. Methods.
Richard, Schlichemeyer, Carole, Chambers, M John, Gill   +2 more
openaire   +2 more sources

Gynecomastia Associated with Highly Active Antiretroviral Therapy

The Annals of Pharmacotherapy, 2001
OBJECTIVE: To report four cases of HIV-associated gynecomastia diagnosed during treatment with nucleoside analogs with or without protease inhibitors. CASE SUMMARY: Four HIV-infected patients developed gynecomastia while taking two ...
R, Manfredi, L, Calza, F, Chiodo
openaire   +2 more sources

Virologic and immunologic response to highly active antiretroviral therapy

Current HIV/AIDS Reports, 2002
Highly active antiretroviral therapy (HAART) delays clinical progression by suppressing viral replication, measured by a substantial reduction in HIV RNA, allowing the immune system to reconstitute, measured in most studies by an increase in CD4 cells. These virologic and immunologic consequences do not occur uniformly among HAART users. Markers of HIV
Lisa P., Jacobson, John P., Phair, Traci E., Yamashita   +2 more
openaire   +3 more sources

Highly Active Antiretroviral Therapy

PharmacoEconomics, 2001
The advent of highly active antiretroviral therapy (HAART), including protease inhibitors and/or non-nucleoside reverse transcriptase inhibitors, for the treatment of HIV infection has led to a dramatic decline of morbidity and mortality. The acquisition costs of HAART are substantial. However, these costs are partially offset by reduced inpatient care
P, Sendi, A J, Palmer, A, Gafni, M, Battegay   +3 more
openaire   +2 more sources